{"id":"https://openalex.org/W4229016408","doi":"https://doi.org/10.1016/j.slast.2021.10.002","title":"Enabling high throughput drug discovery in 3D cell cultures through a novel bioprinting workflow","display_name":"Enabling high throughput drug discovery in 3D cell cultures through a novel bioprinting workflow","alternate_titles":[],"publication_year":2022,"publication_date":"2022-01-25","ids":{"openalex":"https://openalex.org/W4229016408","doi":"https://doi.org/10.1016/j.slast.2021.10.002","pmid":"https://pubmed.ncbi.nlm.nih.gov/35058203"},"language":"en","primary_location":{"id":"doi:10.1016/j.slast.2021.10.002","doi":"https://doi.org/10.1016/j.slast.2021.10.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.slast.2021.10.002","pdf_url":"http://slas-technology.org/article/S2472630321000029/pdf","source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4229016408"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://slas-technology.org/article/S2472630321000029/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045863890","display_name":"Martin Engel","orcid":"https://orcid.org/0000-0001-7602-1340","observed_orcids":["https://orcid.org/0000-0001-7602-1340"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Martin Engel","raw_affiliation_strings":["Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia. Electronic address: martin.engel@inventia.life","Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia. Electronic address: martin.engel@inventia.life","institution_ids":[]},{"raw_affiliation_string":"Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030947594","display_name":"Lisa Belfiore","orcid":"https://orcid.org/0000-0003-1554-7319","observed_orcids":["https://orcid.org/0000-0003-1554-7319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Belfiore","raw_affiliation_strings":["Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051190193","display_name":"Behnaz Aghaei\u2010Ghareh\u2010Bolagh","orcid":"https://orcid.org/0000-0002-1345-7224","observed_orcids":["https://orcid.org/0000-0002-1345-7224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Behnaz Aghaei","raw_affiliation_strings":["Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inventia Life Science Operations Pty Ltd, Alexandria, NSW 2015, Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034357470","display_name":"Margareta Sutija","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Margareta Sutija","raw_affiliation_strings":["PerkinElmer Pty Ltd, Glen Waverley, VIC 3150, Australia. Electronic address: Margareta.Sutija@perkinelmer.com","PerkinElmer Pty Ltd, Glen Waverley, VIC 3150, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PerkinElmer Pty Ltd, Glen Waverley, VIC 3150, Australia. Electronic address: Margareta.Sutija@perkinelmer.com","institution_ids":[]},{"raw_affiliation_string":"PerkinElmer Pty Ltd, Glen Waverley, VIC 3150, Australia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5034357470","https://openalex.org/A5045863890"],"corresponding_institution_ids":[],"apc_list":{"value":1800,"currency":"USD","value_usd":1800},"apc_paid":{"value":1800,"currency":"USD","value_usd":1800},"fwci":2.9013,"has_fulltext":true,"cited_by_count":59,"citation_normalized_percentile":{"value":0.92102934,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"27","issue":"1","first_page":"32","last_page":"38"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10379","display_name":"Cellular Mechanics and Interactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/3d-cell-culture","display_name":"3D cell culture","score":0.9070000052452087},{"id":"https://openalex.org/keywords/bioprinting","display_name":"bioprinting","score":0.9850000143051147},{"id":"https://openalex.org/keywords/high-throughput-drug-screening","display_name":"high-throughput drug screening","score":0.7599999904632568},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8109999895095825},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9810000061988831},{"id":"https://openalex.org/keywords/fibroblasts","display_name":"fibroblasts","score":0.8320000171661377},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/gsk-3beta-phosphorylation","display_name":"GSK3\u03b2 phosphorylation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8939999938011169},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9509999752044678},{"id":"https://openalex.org/keywords/alphalisa","display_name":"AlphaLISA","score":0.796999990940094},{"id":"https://openalex.org/keywords/2d-vs-3d-culture-comparison","display_name":"2D vs 3D culture comparison","score":0.6209999918937683},{"id":"https://openalex.org/keywords/drug-response-prediction","display_name":"drug response prediction","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C163688615","wikidata":"https://www.wikidata.org/wiki/Q15883629","display_name":"3D cell culture","level":3,"score":0.616202175617218},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5471193194389343},{"id":"https://openalex.org/C2780381497","wikidata":"https://www.wikidata.org/wiki/Q463418","display_name":"Fibroblast","level":3,"score":0.5270103216171265},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.5049026608467102},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4886648952960968},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4547230303287506},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4150509834289551},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.39254534244537354},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3801952004432678},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3698059320449829},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36740440130233765},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.1677754521369934},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08735513687133789},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000087603","descriptor_name":"Cell Culture Techniques, Three Dimensional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018874","descriptor_name":"Spheroids, Cellular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D057188","descriptor_name":"Workflow","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062028","descriptor_name":"Bioprinting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.slast.2021.10.002","doi":"https://doi.org/10.1016/j.slast.2021.10.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.slast.2021.10.002","pdf_url":"http://slas-technology.org/article/S2472630321000029/pdf","source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},{"id":"doi:10.1101/2021.04.21.440768","doi":"https://doi.org/10.1101/2021.04.21.440768","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2021.04.21.440768","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2021/04/22/2021.04.21.440768.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:35058203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35058203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS technology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:83a72ad505b1415885982cdc9a14a500","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/83a72ad505b1415885982cdc9a14a500","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SLAS Technology, Vol 27, Iss 1, Pp 32-38 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.slast.2021.10.002","doi":"https://doi.org/10.1016/j.slast.2021.10.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.slast.2021.10.002","pdf_url":"http://slas-technology.org/article/S2472630321000029/pdf","source":{"id":"https://openalex.org/S4387277866","display_name":"SLAS TECHNOLOGY","issn_l":"2472-6303","issn":["2472-6303","2472-6311"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4229016408.pdf","grobid_xml":"https://content.openalex.org/works/W4229016408.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1567661465","https://openalex.org/W1980324695","https://openalex.org/W2020105159","https://openalex.org/W2036453287","https://openalex.org/W2041458399","https://openalex.org/W2051766214","https://openalex.org/W2058928888","https://openalex.org/W2066964642","https://openalex.org/W2114067189","https://openalex.org/W2123061071","https://openalex.org/W2263885780","https://openalex.org/W2411861865","https://openalex.org/W2414236267","https://openalex.org/W2462818054","https://openalex.org/W2473912994","https://openalex.org/W2597848216","https://openalex.org/W2626725994","https://openalex.org/W2781664750","https://openalex.org/W2788914936","https://openalex.org/W2791017844","https://openalex.org/W2791956807","https://openalex.org/W2969825469","https://openalex.org/W2980581402","https://openalex.org/W3001425747","https://openalex.org/W3009670898","https://openalex.org/W3044158710","https://openalex.org/W3044551441","https://openalex.org/W3088868224","https://openalex.org/W3119819455","https://openalex.org/W3132259578","https://openalex.org/W3136050734","https://openalex.org/W3163607354","https://openalex.org/W3174220715","https://openalex.org/W6739468455"],"related_works":["https://openalex.org/W6939734038","https://openalex.org/W2914997530","https://openalex.org/W2962989733","https://openalex.org/W4317733587","https://openalex.org/W2148346304","https://openalex.org/W1623066125","https://openalex.org/W2741638492","https://openalex.org/W4225127490","https://openalex.org/W2508503929","https://openalex.org/W3184877234"],"abstract_inverted_index":{"Advanced":[0],"three":[1],"dimensional":[2],"cell":[3,34,184,211,218,229],"culture":[4,35,190,198,219],"techniques":[5],"have":[6],"been":[7],"adopted":[8],"in":[9,15,37,75,155,216,236],"many":[10],"laboratories":[11],"to":[12,120,231,235],"better":[13],"model":[14],"vivo":[16,237],"tissue":[17],"by":[18],"recapitulating":[19],"multi-cellular":[20],"architecture":[21],"and":[22,47,84,86,91,113,135,157,200],"the":[23,56,62,70,73,93,97,109,168,177,181,195,233],"presence":[24],"of":[25,72,180,194,202],"extracellular":[26,143],"matrix":[27],"features.":[28],"We":[29],"describe":[30],"here":[31],"a":[32,38,148,224],"3D":[33,76,112,158,161,183,210],"platform":[36],"small":[39],"molecule":[40],"screening":[41,65,204,220],"workflow":[42],"that":[43,207],"uses":[44],"traditional":[45,203],"biomarker":[46],"intracellular":[48,138],"kinase":[49],"end":[50],"point":[51],"assay":[52,66],"readouts.":[53],"By":[54],"combining":[55],"high":[57,63],"throughput":[58,64],"bioprinter":[59],"RASTRUM":[60],"with":[61,80,101,108,160,186],"AlphaLISA,":[67],"we":[68,95,175],"demonstrate":[69,176],"utility":[71],"protocol":[74],"synthetic":[77],"hydrogel":[78],"cultures":[79,100,105,116,185,212],"breast":[81,98],"cancer":[82,99],"(MDA-MB-231":[83],"MCF-7)":[85],"fibroblast":[87,104,162],"cells.":[88],"To":[89],"establish":[90],"validate":[92],"workflow,":[94,196],"treated":[96],"doxorubicin,":[102],"while":[103,123,222],"were":[106,117],"stimulated":[107],"pro-inflammatory":[110],"lipopolysaccharide.":[111],"2D":[114,156,189,217],"MDA-MB-231":[115],"equally":[118],"susceptible":[119],"doxorubicin":[121],"treatment,":[122],"showing":[124],"opposite":[125],"ERK":[126],"phosphorylation":[127],"changes.":[128],"Doxorubicin":[129],"readily":[130],"entered":[131],"embedded":[132],"MCF-7":[133],"spheroids":[134],"markedly":[136],"reduced":[137],"GSK3\u03b2":[139],"phosphorylation.":[140],"Furthermore,":[141],"quantifying":[142],"interleukin":[144],"6":[145],"levels":[146],"showed":[147],"very":[149],"similar":[150],"activation":[151],"profile":[152],"for":[153],"fibroblasts":[154],"cultures,":[159],"networks":[163],"being":[164],"more":[165,225],"resistant":[166],"against":[167],"immune":[169],"challenge.":[170],"Through":[171],"these":[172],"validation":[173],"experiments":[174],"full":[178],"compatibility":[179],"bioprinted":[182],"several":[187],"widely-used":[188],"assays.":[191],"The":[192],"efficiency":[193],"minimal":[197],"handling,":[199],"applicability":[201],"assays,":[205],"demonstrates":[206],"advanced":[208],"encapsulated":[209],"can":[213],"be":[214],"used":[215],"workflows,":[221],"providing":[223],"holistic":[226],"view":[227],"on":[228],"biology":[230],"increase":[232],"predictability":[234],"drug":[238],"response.":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4229016408","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":6}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2022-05-08T00:00:00"}
